RIVAROXABAN Sandoz vasc cpr pell 2.5 mg 196 pce
7680688040050
Pharmacode 7842163
CH-68804
B01AF01
06.03.0.
Active substances:
Fiches Amavita / Sun Store / Coop Vitality
Details
- GTIN
- 7680688040050
- Pharmacode
- 7842163
- Product number
- 6880401
- CPT
- -
- Packaging group
- 196
- Unit
- Tablette(n)
- Composition
- rivaroxabanum 2.5 mg, lactosum monohydricum 36.275 mg, natrii laurilsulfas, hypromellosum, croscarmellosum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, hypromellosum, E 171, macrogolum 3350, E 102 0.057 mg, E 132, E 110 0.0006 mg, pro compresso obducto corresp. natrium 0.27 mg.
Articles (1)
Rivaroxaban Sandoz vascular 2,5 mg, Filmtabletten
Filmtabletten
196
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rivaroxabanum
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
36.275 MG | Substance | HBESI |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
hypromellosum
|
- | Substance | HNIDK |
|
croscarmellosum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
E 102
|
0.057 MG | Substance | HBESI |
|
E 132
|
- | Substance | FIMDK |
|
E 110
|
0.0006 MG | Substance | HBESI |
|
natrium
|
0.27 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 118.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2024
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68804
- Drug name
- Rivaroxaban Sandoz vascular, Filmtabletten
- Galenic form
- FILM
- ATC Code
- B01AF01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/10/2022
- Authorization expiration date
- 09/10/2027
- IT number
- 06.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIVAROXABAN Sandoz vasc cpr pell 2.5 mg 196 pce
- Description (DE)
- RIVAROXABAN Sandoz vasc Filmtabl 2.5 mg 196 Stk
- Market launch
- 10/10/2022
- Narcotic (BTM)
- No